Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Mersana Therapeutics Inc (MRSN)
Mersana Therapeutics Inc (MRSN) Financials

MRSN Mersana Therapeutics Inc

2.04

0.06 (3.03%)

23 Nov 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-22.93	-32.83	-61.426	-30.324	-46.225	-70.931	-75.571	-61.267
Return on Equity (%)	27.871	-538.532	-163.112	-64.762	-57.47	-97.225	-191.033	-266.236
Return on Invested Capital (%)	27.889	-2563.378	-197.658	-68.146	-56.404	-89.927	-156.15	-203.99
Operating Margin (%)	-54.428	-220.616	-606.541	-66.41	-10590.097	-392541.86	-755.743	-454.747
Net Profit Margin (%)	-54.428	-220.616	-606.541	-66.966	-10633.454	-395488.372	-768.263	-465.798
Book Value Per Share	-9.548	3.075	0.379	1.726	3.313	1.652	0.884	0.306
Earnings Per Share	-2.352	-1.7	-2.766	-0.621	-1.279	-2.307	-1.961	-1.424
Cash Per Share	17.218	1.168	2.567	1.374	3.706	2.414	1.237	1.448
Working Capital Per Share	12.667	3.763	0.21	1.702	3.32	1.918	2.186	1.247
Operating Profit Per Share	4.321	0.771	0.456	0.928	0.012	0.001	0.255	0.306
EBIT Per Share	-2.352	-1.7	-2.766	-0.621	-1.279	-2.307	-1.961	-1.424
EBITDA Per Share	-2.352	-1.7	-2.766	-0.621	-1.279	-2.307	-1.961	-1.424
Free Cash Flow Per Share	-2.278	-1.691	-2.761	-0.636	-1.287	-2.31	-1.948	-1.418

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	5.83M	22.77M	23.23M	45.39M	68.84M	73.71M	104.16M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	98.58M	104.16M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-707.255	N/A	N/A	N/A	-197.988	N/A
Net Profit Margin (%)	N/A	N/A	-719.854	N/A	N/A	N/A	-208.826	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	244.6M
Price to Earnings Ratio	-1.47
Price to Sales Ratio	6.84
Price to Cash Ratio	1.44
Price to Book Ratio	6.83
Dividend Yield	-

Share Statistics

Shares Outstanding	123.53M
Average Volume (1 week)	1.11M
Average Volume (1 Month)	1.25M
52 Week Change	27.50%
52 Week High	6.2801
52 Week Low	1.22

More Ratios Coming Soon!

Mersana Therapeutics

Annaly Capital Management

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions